HALO logo
halo search icon
Belite Bio, Inc. ADR

US$143.36

Price Change Indicator
3.66 (2.62%)
Belite Bio, Inc. ADR
BLTE · NAS

Belite Bio, Inc. ADR

Start Trading BLTE for Free

US$143.36

Price Arrow3.66 (2.62%)
20/05/2026 04:00:00 PM
All-ConsensusHammer Bullish (Realtime)Near Support
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Belite Bio, Inc. ADR Overview

BLTE Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About BLTE

icon

Website

Belite Bio, Inc. ADR

icon

Telephone

1.858.246.6240

icon

Address

Suite 475, 12750 High Bluff Drive, San Diego, CA 92130

Description

Belite Bio, Inc. engages in the research and development of drugs. It focuses on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.

BLTE Price Chart

Key Stats

Market Cap

US$5.58B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 56.1 - 200

Trade Value (12mth)

US$4,648,379.00

1 week

-2.31%

1 month

-15.45%

YTD

-12.29%

1 year

107.61%

All time high

200.00

Key Fundamentals

EPS 3 yr Growth

265.50%

EBITDA Margin

0.00%

Operating Cashflow

-$37m

Free Cash Flow Return

-8.10%

ROIC

-16.90%

Interest Coverage

0.00

Quick Ratio

50.00

Other Data

Shares Outstanding (Fully Diluted)

36m

HALO Sector

Healthcare

Next Company Report Date

26-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

BLTE Announcements

Latest Announcements

DateAnnouncements
20 May 26
22 April 26
31 March 26
31 March 26
02 March 26

BLTE Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.19-1.18-2.31locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.19-1.18-2.31locklocklock
Growth
 %locklocklocklock-87.90.5-95.5locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Belite Bio, Inc. ADR (BLTE:NAS)?
Halo FAQ
The current share price of Belite Bio, Inc. ADR (BLTE:NAS) is USD$143.36.
What is the 52-week high share price for Belite Bio, Inc. ADR (BLTE:NAS)?
Halo FAQ
The 52-week high share price for Belite Bio, Inc. ADR (BLTE:NAS) is USD$200.00.
What is the 52-week low share price for Belite Bio, Inc. ADR (BLTE:NAS)?
Halo FAQ
The 52-week low share price for Belite Bio, Inc. ADR (BLTE:NAS) is USD$56.10.
What is the dividend yield for Belite Bio, Inc. ADR (BLTE:NAS)?
Halo FAQ
Belite Bio, Inc. ADR (BLTE:NAS) does not pay a dividend.
What was Belite Bio, Inc. ADR (BLTE:NAS) last dividend payment?
Halo FAQ
Belite Bio, Inc. ADR (BLTE:NAS) does not pay a dividend.
What is the franking level for Belite Bio, Inc. ADR (BLTE:NAS)?
Halo FAQ
Belite Bio, Inc. ADR (BLTE:NAS) has a franking level of 0.00%.
In which sector is Belite Bio, Inc. ADR (BLTE:NAS) classified?
Halo FAQ
Belite Bio, Inc. ADR (BLTE:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial